Peter Libby, MD, on Clonal Hematopoiesis of Indeterminate Potential and Atherosclerosis
In this podcast, Peter Libby, MD, gives an overview of clonal hematopoiesis of indeterminate potential, how it relates to cardiovascular medicine, and why it should be on your radar.
Peter Libby, MD, is a cardiology specialist at Brigham and Women’s Hospital and the Mallinckrodt Professor of Medicine at Harvard Medical School in Boston Massachusetts.
Additional Resources:
Bick AG, Pirruccello JP, Griffin GK, et al. Genetic IL-6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis [published online November 11, 2019]. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.119.044362.
Jaiswal S, Libby P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease [published online August 12, 2019]. Nat Rev Cardiol. https://doi.org/10.1038/s41569-019-0247-5.
- Lin AE, Libby P, Ebert BL. A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis [published online October 21, 2019]. Eur Heart J. https://doi.org/10.1093/eurheartj/ehz752.
Note: Dr Libby does not endorse any products or services advertised on this page.
